๐๏ธ OncologyInjection (SC)
Epkinly
Epcoritamab
CD20-CD3 bispecific antibody administered subcutaneously for relapsed/refractory DLBCL.
Form
Injection (SC)
Uses
2
Side effects
5
Category
Oncology
01
What is Epkinly used for?
- Relapsed/refractory diffuse large B-cell lymphoma
- Large B-cell lymphoma
02
Epcoritamab side effects
Common side effects of Epcoritamab include:
Cytokine release syndrome
Fatigue
Injection site reactions
Musculoskeletal pain
ICANS
CommonModerateLess common
03
Epcoritamab warnings & precautions
- Black box: CRS and neurologic toxicity (ICANS)
- REMS program
- Step-up dosing required
Loading FDA dataโฆ
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Epkinly in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.